vimarsana.com

Page 5 - எங்களுக்கு ஒழுங்குமுறை அதிகாரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Die Grossmutter, die J P Morgan und ihre Enkel verklagt

Die Grossmutter, die J P Morgan und ihre Enkel verklagt
finews.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finews.ch Daily Mail and Mail on Sunday newspapers.

Amazon: Millionen-Strafe, Chefwechsel & starke Zahlen! Die Aktie zieht an

Amazon: Millionen-Strafe, Chefwechsel & starke Zahlen! Die Aktie zieht an
boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.

Quantum Genomics Launches Phase III Pivotal REFRESH Study in Difficult-to-treat/Resistant Hypertension with Once-a-day Formulation of Firibastat

Share: PARIS and NEW YORK, Jan. 18, 2021 (GLOBE NEWSWIRE) Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in developing a new drug class that directly targets the brain to treat difficult-to-treat and resistant hypertension and heart failure today announced the launch of its Phase III REFRESH study in difficult-to-treat ( (2) hypertension. This new study is part of firibastat s Phase III clinical development and aims to assess long-term safety as well as the three-month efficacy after a single daily dose of firibastat 1000mg in treatment resistant hypertensive patients. We are thrilled to launch this new pivotal study as a precursor to potential market approval of single dose firibastat, which we believe to be the best regimen for chronic treatment of resistant of difficult-to-treat hypertension, said Jean-Philippe Milon, Chief Executive Officer at Quantum Genomics.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.